Kaito Y, Sugimoto E, Nakamura F, Tsukune Y, Sasaki M, Yui S, Yamaguchi H, Goyama S, Nannya Y, Mitani K, Tamura H, Imai Y. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia. haematol [Internet]. 2024Mar.31 [cited 2024May20];109(4):1107-20. Available from: https://haematologica.org/article/view/haematol.2023.282915